发文分析
近年国家/地区发文量统计
| 国家/地区 | 数量 |
|---|---|
| USA | 3013 |
| Spain | 1642 |
| France | 1618 |
| Japan | 1599 |
| Italy | 1561 |
| CHINA MAINLAND | 1521 |
| England | 1454 |
| GERMANY (FED REP GER) | 1273 |
| South Korea | 899 |
| Netherlands | 656 |
近年机构发文量统计
| 机构 | 数量 |
|---|---|
| UNICANCER | 1099 |
| HARVARD UNIVERSITY | 602 |
| UNIVERSITY OF TEXAS SYSTEM | 552 |
| NATIONAL CANCER CENTER - JAPAN | 527 |
| UNIVERSITY OF LONDON | 516 |
| HOSPITAL UNIVERSITARI VALL D'HEBRON | 465 |
| MEMORIAL SLOAN KETTERING CANCER CENTER | 452 |
| ASSISTANCE PUBLIQUE HOPITAUX PARIS (APHP) | 417 |
| UNIVERSITY OF CALIFORNIA SYSTEM | 412 |
| VALL D'HEBRON INSTITUT D'ONCOLOGIA (VHIO) | 373 |
近年文章引用他刊数据
| 文章名称 | 引用次数 |
|---|---|
| 4th ESO-ESMO International Consensus Guidelines for Adva... | 266 |
| Metastatic non-small cell lung cancer: ESMO Clinical Pra... | 242 |
| Development of tumor mutation burden as an immunotherapy... | 201 |
| Early breast cancer: ESMO Clinical Practice Guidelines f... | 138 |
| Man against machine: diagnostic performance of a deep le... | 136 |
| Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical... | 133 |
| Negative association of antibiotics on clinical activity... | 122 |
| Five-year survival outcomes for patients with advanced m... | 104 |
| Renal cell carcinoma: ESMO Clinical Practice Guidelines ... | 104 |
| Immune checkpoint inhibitors for patients with advanced ... | 102 |
近年被他刊引用数据
| 期刊名称 | 引用次数 |
|---|---|
| CANCERS | 1133 |
| ANN ONCOL | 721 |
| FRONT ONCOL | 663 |
| BMC CANCER | 547 |
| FUTURE ONCOL | 469 |
| SCI REP-UK | 449 |
| INT J MOL SCI | 429 |
| CLIN CANCER RES | 427 |
| EUR J CANCER | 421 |
| BREAST CANCER RES TR | 403 |